| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| QSAM Biosciences, Inc. | General Counsel & Executive VP | Common Stock | 0 | $0 | $3.00 | 02 May 2024 | Direct |
| QSAM Biosciences, Inc. | General Counsel & Executive VP | Series B | 4.56K | 23 Jun 2023 | Direct | ||
| QSAM Biosciences, Inc. | General Counsel & Executive VP | Options to buy common stock | 255 | 06 Feb 2024 | Direct | ||
| QSAM Biosciences, Inc. | General Counsel & Executive VP | Series B Convertible Preferred Stock | 0 | 06 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QSAM | QSAM Biosciences, Inc. | 02 May 2024 | 1 | $0 | 4 | General Counsel & Executive VP | 02 May 2024, 10:32 |
| QSAM | QSAM Biosciences, Inc. | 06 Feb 2024 | 2 | $0 | 4/A | EVP Corp Dev & General Counsel | 14 Feb 2024, 16:43 |
| QSAM | QSAM Biosciences, Inc. | 06 Feb 2024 | 2 | $0 | 4 | EVP Corp Dev & General Counsel | 13 Feb 2024, 16:00 |
| QSAM | QSAM Biosciences, Inc. | 23 Jun 2023 | 1 | $0 | 4 | EVP Corp Dev & General Counsel | 23 Jun 2023, 16:30 |
| QSAM | QSAM Biosciences, Inc. | 31 Dec 2022 | 1 | $0 | 4 | General Counsel | 04 Jan 2023, 16:11 |
| QSAM | QSAM Biosciences, Inc. | 03 Mar 2022 | 1 | $0 | 4 | General Counsel | 07 Mar 2022, 19:02 |
| QSAM | QSAM Biosciences, Inc. | 31 Dec 2021 | 6 | $400K | 5 | General Counsel and Director, Director | 14 Feb 2022, 20:58 |